Open-label, add-on trial of cetirizine for neuromyelitis optica
Ilana Katz Sand(Icahn School of Medicine at Mount Sinai), Fred Lublin(Icahn School of Medicine at Mount Sinai), Lawrence J. Cook(University of Utah), John Rose(VA Salt Lake City Healthcare System), Shelly Ebel(University of Utah), Thomas M. Moran(University of Utah), Thomas Kraus(University of Utah), Michelle Fabian(Icahn School of Medicine at Mount Sinai), Mirna Chehade(Icahn School of Medicine at Mount Sinai), Madhan Masilamani(ENT and Allergy), Russell Telford(University of Utah), Colleen Farrell(University of Utah)
Cited by 26
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k